Literature DB >> 7114944

Esophagectomy: definitive treatment for esophageal neuromotor dysfunction.

M B Orringer, J S Orringer.   

Abstract

Twenty-two patients with a history of between one and four (average of two) unsuccessful prior esophageal operations for neuromotor dysfunction were treated with esophageal resection and replacement. Eleven (50%) had recurred reflux esophagitis in association with various disorders of motility: esophageal spasm in 4, achalasia in 3, scleroderma in 2, and esophageal atresia in 2. Eight (36%) had primary esophageal spasm and 3 (14%) had achalasia. Esophageal obstruction, regurgitation, and severe spasm were the most common manifestations of the inability to swallow normally. Transthoracic or transhiatal (blunt) esophagectomies were performed in 5 and 17 patients, respectively. The stomach, with a cervical esophagogastric anastomosis, was used for esophageal substitution in 15 patients. Six patients underwent a long-segment colonic interposition, and 1 patient with achalasia underwent a distal esophagectomy and short-segment colonic interposition. One patient undergoing transthoracic esophagectomy for achalasia died from unrecognized intraoperative bleeding into the opposite chest. There were no other operative deaths. Additional complications included transient hoarseness in 8 patients, chylothorax in 1, and anastomotic leak in 1. After an average follow-up of 25 months for the 21 surviving patients, ability to eat is regarded as good in 18 (85%), fair in 1 (5%), and poor in 2 (10%). In patients with incapacitating esophageal neuromotor disease, a more radical operative approach-esophagectomy--may be safer and more reliable than attempting another procedure and risking another failure. Esophagectomy ensures definitive elimination of the esophageal problem and as optimal an ability to eat as possible. Our experience suggests that the stomach, with a cervical esophagogastric anastomosis, offers a better functional esophageal substitute than does a colonic interposition.

Entities:  

Mesh:

Year:  1982        PMID: 7114944     DOI: 10.1016/s0003-4975(10)62492-7

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  9 in total

Review 1.  Endoscopic and Surgical Treatments for Achalasia: Who to Treat and How?

Authors:  Romulo A Fajardo; Roman V Petrov; Charles T Bakhos; Abbas E Abbas
Journal:  Gastroenterol Clin North Am       Date:  2020-06-26       Impact factor: 3.806

2.  Fluoroscopically guided balloon dilation of the esophagus.

Authors:  Kevin J Blount; Drew L Lambert; Hubert A Shaffer; Eduard E de Lange
Journal:  Semin Intervent Radiol       Date:  2010-06       Impact factor: 1.513

Review 3.  Role and safety of fundoplication in esophageal disease and dysmotility syndromes.

Authors:  Charles T Bakhos; Roman V Petrov; Henry P Parkman; Zubair Malik; Abbas E Abbas
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

Review 4.  Surgical treatment of primary esophageal motility disorders.

Authors:  Fernando A Herbella; Ana C Tineli; Jorge L Wilson; Jose C Del Grande
Journal:  J Gastrointest Surg       Date:  2007-11-13       Impact factor: 3.452

5.  Gastric interposition following transhiatal esophagectomy: radiographic evaluation.

Authors:  F P Agha; M B Orringer; M A Amendola
Journal:  Gastrointest Radiol       Date:  1985

6.  Abdominocervical oesophagectomy in the elderly.

Authors:  R C Williamson
Journal:  Ann R Coll Surg Engl       Date:  1985-11       Impact factor: 1.891

7.  Esophageal diverticulosis.

Authors:  Karina Witkiewicz; Janusz Wójcik; Jarosław Pieróg; Norbert Wójcik; Bogumił Maciąg; Tomasz Grodzki
Journal:  Kardiochir Torakochirurgia Pol       Date:  2017-06-30

8.  Surgical Treatment of Esophageal Achalasia in the Era of Minimally Invasive Surgery.

Authors:  László Andrási; Attila Paszt; Zsolt Simonka; Szabolcs Ábrahám; Márton Erdős; András Rosztóczy; Georgina Ollé; György Lázár
Journal:  JSLS       Date:  2021 Jan-Mar       Impact factor: 2.172

9.  Total gastrectomy in systemic scleroderma when anti-reflux surgery is not viable: A case report.

Authors:  Carlos Jose Perez Rivera; Akram Kadamani Abiyomaa; Alejandro González-Orozco; Maria Antonia Ocampo; Isabella Caicedo; Manuel Santiago Mosquera
Journal:  Int J Surg Case Rep       Date:  2019-08-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.